Primary endpoint of endoscopic nasal polyp score (NPS) showed reduction of -1.95 (p < 0.0001) in new analysis with adjustment for ...

Phase 3 LIBERTY-AIMS results showed dupilumab reduced nasal polyp size and sinus symptoms in adults and children with allergic fungal rhinosinusitis.

Tezepelumab is associated with beneficial changes in nasal polyp gene expression in patients with chronic rhinosinusitis with ...

An asthma drug has shown positive results when used to treat nasal polyps, researchers have said. Tezepelumab was first approved for treating asthma in 2021, but new research led by a University of ...

Treatment with SCS is still common among patients with CRSwNP with or without comorbid asthma, despite the availability of ...

The nose is the subject of many sayings. A measurement could be on the nose or an object be right under your nose. You may be reminded to keep your nose clean and keep it out of another's affairs.

Women using estrogen-containing contraceptives vs. not using any systemic hormonal contraceptives had reduced odds for ...

The nose is the subject of many sayings. A measurement could be on the nose or an object right under your nose. You may be reminded to keep your nose clean and out of another’s affairs. While often ...

Spring allergy season can be a double problem for some people. On top of allergies, they also have blocked sinuses, and surgery may be the only path to relief. Allergy sufferers are most at risk of ...

SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for further treatments, the WAYPOINT trial showed. The monoclonal ...